Comparison of the ADVIA centaur® and Abbott AxSYM immunoassay systems for a routine diagnostic virology laboratory

Journal of Clinical Virology

Volumn 30, Issue SUPPL. 1, 2004, Pages S10-S14

  Taylor, Paul ^a   Pickard, Graham ^a   Gammie, Alistair ^b   Atkins, Mark ^a  

^a IMPERIAL COLLEGE HEALTHCARE NHS TRUST   (United Kingdom)

^b Bayer plc UK   (United Kingdom)

Author keywords

ADVIA Centaur; Automation; AxSYM; Diagnostic virology; Immunoassays

Indexed keywords

HEPATITIS B ANTIGEN; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIBODY; HEPATITIS C ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; IMMUNOGLOBULIN M ANTIBODY;

ANTIBODY DETECTION; ARTICLE; AUTOANALYZER; AUTOMATION; BLOOD SAMPLING; DIAGNOSTIC ACCURACY; FREEZING; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOASSAY; INTERMETHOD COMPARISON; PRIORITY JOURNAL; THAWING; VIRUS DIAGNOSIS;

EID: 1942451855     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcv.2004.02.004     Document Type: Article

References (9)

1. Cameron S.O., Stewart J., Davidson M., Ho-Yen D. Problems of an automated testing system for hepatitis B. Commun. Dis. Public Health. 3:2000;141-142.
2. Costongs G.M., Van Oers R.J., Leerkens B., Hermans W., Janson P.C. Evaluation of the Abbott automated random, immediate and continuous access immunoassay analyser, the AxSYM. Eur. J. Clin. Chem. Clin. Biochem. 33:1995;105-1011.
3. Day R.G., Horschke W.A., Hallahan M.-T., Jackson T., Williams J.S. System design solutions for high volume immunoassay analysis. J. Clin. Lig. Assay. 22(2):1999;184-193.
4. Ferrer F., Candela M.-J., Garcia C., Martinez L., Rivera J., Vicente V. A comparative study of two third generation anti-hepatitis C virus elisas. Haematologica. 82:1997;690-691.
5. Feucht H.-H., Zollner B., Polywka S., Laufs R. study on reliability of commercially available hepatitis C virus antibody assays. J. Clin. Microbiol. 33:1995;620-624.
6. Heijtink R.A., Schneeberger P.M., Postma B., Crombach W. Anti-HBs levels after hepatitis B immunisation depend on test reagents: routinely determined 10 and 100 IU/l seroprotection levels unreliable. Vaccine. 20:2002;2899-2905.
7. McCartney R.A., Harbour J., Roome A.P., Caul F.O. Comparison of enhanced chemiluminescence and microparticle enzyme immunoassay for the measurement of hepatitis B surface antibody. Vaccine. 11(9):1993;941-945.
8. Schwartz D.H., Mazumdar A., Winston S., Harkonen S. Utility of various commercially available human immunodeficiency virus (HIV) antibody diagnostic kits for use in conjunction with efficacy trials of HIV-1 vaccines. Clin. Diagn. Lab. Immunol. 2:1995;268-271.
9. Smith J., Osikowicz G. Abbott AxSYM random and continuous access immunoassay system for improved workflow in the clinical laboratory. Clin. Chem. 39:1993;2063-2069.